Evidence map›Paper›PMID 35573939›Full record

ArticleFrontiers in pediatrics2022

Non-convulsive Status Epilepticus in

Jing Duan, Yan Chen, Zhanqi Hu, Yuanzhen Ye, Tian Zhang, Cong Li, Qi Zeng, Xia Zhao, Jiahui Mai, Yang Sun and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A novelFrontiers in genetics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Jing DuanDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Yan ChenDepartment of Epilepsy Surgery, Shenzhen Children's Hospital, Shenzhen, China.
Zhanqi HuDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Yuanzhen YeDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Tian ZhangDepartment of Epilepsy Surgery, Shenzhen Children's Hospital, Shenzhen, China.
Cong LiDepartment of Epilepsy Surgery, Shenzhen Children's Hospital, Shenzhen, China.
Qi ZengDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Xia ZhaoDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Jiahui MaiDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Yang SunDepartment of Epilepsy Surgery, Shenzhen Children's Hospital, Shenzhen, China.
Chao LiuDepartment of Bioinformatics, Berry Genomics Co., Ltd., Beijing, China.
Wenxin ZhengDepartment of Bioinformatics, Berry Genomics Co., Ltd., Beijing, China.
Yuhan XiaoDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Jianxiang LiaoDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Li ChenDepartment of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
Shenzhen Children's Hospital · CNBerry Oncology (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive myoclonic epilepsy (PME) is a group of rare diseases characterized by progressive myoclonus, cognitive impairment, ataxia, and other neurologic deficits. PME has high genetic heterogeneity, and more than 40 genes are reportedly associated with this disorder.

Indexed as

frameshift mutationnon-convulsive status epilepticus (NCSE)piracetamprogressive myoclonic epilepsySEMA6B

Identifiers

PMID35573939
PMCPMC9096209
OpenAlexW4285741110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.